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The grand challenges of schizophrenia research are linking the causes of the disorder to
its symptoms and finding ways to overcome those symptoms. We argue that the field
will be unable to address these challenges within psychiatry’s standard neo-Kraepelinian
(DSM) perspective. At the same time the current corrective, based in molecular genetics
and cognitive neuroscience, is also likely to flounder due to its neglect for psychiatry’s
syndromal structure. We suggest adopting a new approach long used in reliability
engineering, which also serves as a synthesis of these approaches. This approach,
known as fault tree analysis, can be combined with extant neuroscientific data collection
and computational modeling efforts to uncover the causal structures underlying the
cognitive and affective failures in people with schizophrenia as well as other complex
psychiatric phenomena. By making explicit how causes combine from basic faults to
downstream failures, this approach makes affordances for: (1) causes that are neither
necessary nor sufficient in and of themselves; (2) within-diagnosis heterogeneity; and
(3) between diagnosis co-morbidity.
Keywords: reliability engineering, fault tree analysis, schizophrenia, DSM-5, research domain criteria, psychosis,
NMDA receptor
The current framework for categorizing psychiatric disorders such as schizophrenia impedes
progress toward the goals of understanding the causes and cures for these illnesses. This article
will describe an alternative framework derived from reliability engineering, a field developed to
study the way in which complex systems break down. Changing a framework is more than window
dressing: frameworks carry the assumptions and affordances that invisibly guide our work. We
will first critique two prominent frameworks in psychiatry. We will then show how a framework
inspired by reliability engineering can help understand the cognitive and affective dysfunctions of
psychosis.
The neo-Kreapelinian framework is named for the founder of modern psychiatry (Kraepelin
and Diefendorf, 1907), built on schemes such as the Feigner criteria (Feighner et al., 1972) and the
Research Diagnostic Criteria (RDC; Spitzer et al., 1975), and was eventually codified in the 3rd
edition of the DSM (DSM-III). These codes used symptoms to determine whether someone fulfilled
the necessary and sufficient conditions for a diagnosis, which assumed the status of a natural
category. Although this made it possible for patients to share a diagnosis without sharing any
symptoms, this level of within-category variation was acceptable if the criteria increased diagnostic
reliability and harmonized practice (but see Markon et al., 2011). Within this framework theories
about how the neural functions of schizophrenia patients are distinct from the neural functions
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of depressed or bipolar patients were immediately salient and
substantive. Four decades later, genetic, cellular, neural, cognitive
and affective dysfunctions are known to be shared across
many distinct diagnostic categories, and even an optimal neo-
Kreapelinian scheme could not sort things out. Fifty percent
of people diagnosed with schizophrenia will fulfill criteria for
comorbid substance abuse, and 50% will fulfill criteria for
depression (Buckley et al., 2009; for additional critique, see
MacDonald, 2013). Such comorbidity likely derives from a
shared vulnerability: the genetic correlation for common SNP’s
between schizophrenia and bipolar disorder may be as high as
0.68, and between schizophrenia and depression may be as high
as 0.47 (Lee et al., 2013). At this point the neo-Kraepelinian
framework helps insurance adjusters more than researchers,
clinicians or patients. For these reasons, there is momentum
toward another framework that we will call informal reverse-
engineering.
Informal reverse-engineering, already implicit in much
psychopathological research, is codified in NIMH’s Research
Domain Criteria (RDoC) program: ‘‘The mandate for RDoC is
to consider psychopathology in terms of maladaptive extremes
along a continuum of normal functioning, to promote a
translational emphasis’’ (Ford et al., 2014, p. S296). The
framework of RDoC is a matrix: rows are different functions
from five categories (positive valence systems, negative valence
systems, cognition, social processes and arousal); columns are
levels of analysis ranging from genes to behavior and symptoms
(Insel and Cuthbert, 2009; Sanislow et al., 2010; Cuthbert
and Kozak, 2013; Ford et al., 2014). Patients can therefore
be characterized in terms of many different functions and
how those functions relate to biological processes or broader
symptoms and social dysfunctions. Moving the focus toward
functional deficits and away from the clinical constellations
of the DSM may enable a tighter link between biology and
behavior in neuropsychiatric research. However, a number of
concerns have already arisen. First, by its structure, RDoC
implies independance across the brains’ multitude of functions
(rows in the RDoCmatrix). Just as DSM categories are comorbid,
so different RDoC functions are often correlated (reminiscent
of general cognitive ability; see also Fowler et al., 2012).
The authors of RDoC are aware of this, but there is little
allowance in the framework for elaborating these relationships.
Second, the RDoC posits that variation in these functions
improves our ability to identify biological mechanisms more
than clinical symptoms can. However, such functions may
turn out to be as complicated as symptoms or diagnoses
(Flint and Munafò, 2007; Kendler and Neale, 2010). Third, the
relationship between these functions and symptoms is weak
at best (Gold et al., 2012), and at times functions associated
with very different neural structures correlate equally well
with symptoms (MacDonald, 2013). The key shortcoming of
the informal reverse-engineering approach in RDoC derives
from isolating constructs from each other and thereby drawing
attention away from the structure of psychopathology. Even
when statistical relationships are discerned, it is not easy
to append these into the cumulative science of mental
illness.
This article will argue for a new framework, borrowed from
reliability engineering, to guide the accumulation of knowledge
and the development of new treatments for mental disorders.
Our focus will be on psychosis, but many of these observations
apply broadly to psychopathology. We will argue that adjusting
the framework fromwhich wemotivate and report our findings is
not only desirable, but is also a necessary step in the cognitive and
affective neuroscience of these disorders. This new perspective
based on a tool called fault tree analysis makes affordances
for examining: (1) how causes that are neither necessary nor
sufficient in and of themselves can result in psychosis; and how
(2) within-diagnosis heterogeneity; and (3) co-morbidity arise.
FAULT TREE ANALYSIS
Fault tree analysis is a tool adapted from reliability engineering,
in which the total likelihood of failure of a system is explained
by the failure likelihood of each of its components (Rausand
and Hoyland, 2004). Originally developed for analysis of rocket
failures, fault trees seek to illustrate how faults of individual
components interact within the system to cause an overall
failure. To generate a fault tree, the different elements of
the device must be identified, as well as their probability of
failure—called faults—and how the faults interact and combine
into failure modes (see Figure 1). A fault means the component
is unable to perform its required function. Depending on other
settings within the system, a small fault may be insignificant
or trigger a cascade leading to a failure mode. In psychiatry,
a failure mode is an impairment in some aspect of cognition,
emotion or behavior of the kind we identify as a mental
disorder.
The failure of a single component rarely results in a general
system failure, due to built-in redundancy and plasticity of the
brain. This enables most people with some forms of insult to
function normally in the world. In this way, fault tree analysis
makes affordances for causes that are neither necessary nor
sufficient to cause dysfunction. Different individuals may come
to a failure mode based on a different set of conditions, which
contributes to within-diagnosis heterogeneity. Similarly, a given
fault may lead to several failure modes, which gives rise to co-
morbidity.
To generate a fault tree, one identifies the different
components that contribute to the failure and for added value,
quantify the likelihood of failure. Importantly, the fault tree
illustrates how faults interact. This can be done with something
like Boolean logic; faults may be related to other faults through
AND or OR relationships (as well as others). This allows one to
predict the probability of a failure mode given specific failures
within the system. To this end, genetic mutations leading to
psychiatric diseases may have measurable fault rates, although
developmental and physiological failure rates will require more
attention to estimate accurately. In addition, treatments can be
modeled as externally-controlled variables in this network used
to alter the outcome. The validity of the fault tree can then
be tested by determining how well the known risks predict the
known characteristics and rates of failure within a population.
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FIGURE 1 | General model of a fault tree. Gene expression changes combine with environmental factors (e.g., stress, brain injury) to affect cellular level processes
(e.g., synaptic plasticity, neurotransmitter release). Logical combinations of alterations in cellular level processes produce changes in particular cognitive or affective
processes (e.g., working memory, mood), which manifest as clinical signs or symptoms. Additional logic combinations (e.g., critical mass: any 4 of 7, etc.) can also
be modeled.
Fault tree analysis is therefore a distinct and unused tool for
understanding how different risk factors and therapies interact.
Whereas the neo-Kraepelinian framework focuses on validating
diagnoses and the informal reverse-engineering framework
focuses on translational accounts of specific cognitive constructs,
the reliability engineering framework attends to the ways in
which faults combine into failure modes, and the ways in which
the natural redundancies built into the brain can break down,
or be built up. In this effort, computational models have a
particularly important role.
Computational Models as the Translational
Glue within Fault Tree Analyses
In many respects computational models—mathematical
formalizations of hypotheses—are already providing the kind
of mechanistic understanding of mental disorders such as
psychosis that fault tree analysis promises. Across all levels of
analysis, computational models provide a means for describing
how a system will respond to perturbations (for review, see
Rolls et al., 2008). Such perturbations might be thought of as
faults—specific malfunctions that either do or do not lead to a
failure mode—or treatments intended to reverse those faults.
Integrating computational modeling with fault-tree analysis in
the context of psychiatric disease allows us to bridge from risk
factors, whose rates serve as the parameters of the model, to
disease pathophysiology, which form the modeled outcome.
Such models suggest links between different faults, and how
those faults at one scale of the fault tree lead to outcomes at
another scale.
For example, genomic studies have identifiedmanymutations
related to schizophrenia, based on weak correlations in very large
samples. These are not direct links from cause to behavioral
outcome. More than 100 risk genes have been identified by
GWAS linkage studies (Schizophrenia Working Group of the
Psychiatric Genomics Consortium, 2014), and the final number
of relevant mutations may be thousands. Computational models
relate what we may know about the functions of these genes
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at the molecular and cellular scale to the observable changes
in physiological biomarkers. The Hodgkin-Huxley neuronal
models simulate ion channel and synaptic conductances to
predict cellular dynamics. Channel mutations can be modeled
by changing parameters and measuring the resulting changes
in excitability and/or spiking patterns. Therefore, these models
link changes at the protein scale to cellular scale biomarkers. At
another scale, mean-field models simulate the average firing rates
of populations of neurons in brain regions. These models can
be used to relate changes in excitability or connection strengths
to the emergence of synchrony and population oscillations that
may be measured in a system-level biomarker, such as changes in
functional MRI (fMRI), electroencephalogram (EEG) and even
to cognitive deficits.
An advantage of computational models is that they can
predict how interventions modulate neural activity to restore
normal functioning. By testing these predictions from the
models, we are inherently testing our underlying hypothesis
of the physiological mechanisms of the disease state. Still,
a challenge modelers share with experimentalists examining
schizophrenia and other complex psychiatric disorders is how
to integrate their models in a way that allows them to be placed
within a larger, cumulative perspective of psychopathology. We
provide the following example of how such findings can fit within
a fault tree analysis.
Generating a Fault Tree: An Example in
Schizophrenia at the Cellular Level
The work of Neymotin et al. (2011) can illustrate how a fault tree
may be generated from the results of empirical research. The goal
of this study was to simulate the effects of administration of the
schizomimetic drug ketamine on hippocampal neuronal
oscillations. Ketamine, an NMDA receptor (NMDAR)
antagonist, elicits an increase in gamma (30–100 Hz) power
and decrease in theta (3–12 Hz) power. The model consisted
of 200 each of basket and oriens-lacunosum moleculare (OLM)
interneurons and 800 hippocampal pyramidal cells and allowed
them to test whether selectively blocking inhibitory circuits led
to more high-frequency activity (Greene, 2001). NMDARs were
present on the somas of each of the three cell types, as well as
on the apical dendrites of pyramidal cells. Blocking NMDARs at
all four locations decreased both theta and gamma power, which
was inconsistent with ketamine effects in biological systems.
A systematic investigation of all 16 possible combinations of
insults demonstrated that pyramidal somatic NMDARs were
largely irrelevant to theta and gamma power, whereas blocking
pyramidal apical NMDARs alone was enough to decrease both
theta and gamma power. The only condition which resulted in
decreased theta and increased gamma was when OLM receptors
were blocked while the basket interneurons and apical pyramidal
receptors remained functional. This result can be translated into
the Boolean logic illustrated in Figure 2.
The finding illustrates a helpful way of thinking: how
do different insults combine to link NMDAR dysfunction to
impairments in the cognitive and emotional functions of patients
with schizophrenia? It may be that the cellular level of analysis
is particularly amenable to fault tree analysis. Fault-tree models
of cell-level malfunctions test causal relations between genetic
mutations and changes in cell and network physiology, and
then link these physiological changes to changes in cognitive
and perceptual functions. Characterizing changes in brain
function at the cellular level will require the development
of appropriate animal models of psychiatric disease. Mutant
mouse models link genetic mutations that increase risk for
schizophrenia in humans to downstream changes in neural and
network function. However, mouse models will be limited in
the extent to which they can replicate cognitive and perceptual
changes that occur in patients with schizophrenia, or the
physiological dynamics of regions like the prefrontal cortex.
Although it is difficult to relate cellular physiology and cortical
network dynamics to downstreammanifestations such as clinical
symptoms, animal models can play an important role here.
For example, ketamine administered to monkeys performing
a cognitive control task show the specific pattern of errors
that is a hallmark of cognitive control failure in patients with
schizophrenia (Blackman et al., 2013). Neural recording during
the period of synaptic malfunction also shows the underlying
changes in cellular physiology and network oscillations that cause
cognitive failures much like those seen in patients (Wang et al.,
2013; Ma et al., 2015). Building links between synaptic, cell, and
network phenomena in the context of behavior should serve to
fill in key elements of fault tree networks.
There are other aspects of fault tree analysis that are not
illustrated in Figure 2, for example the potential for two or
more different combinations of insults to produce the same
downstream effect, and modeling of non-binary outcomes using
more complicated algorithms. Amore complex model with more
types of cells and insults may have revealed several mechanisms
by which a decrease in theta power and increase in gamma power
may result.
A FAULT TREE-ALIGNED RESEARCH
AGENDA: IMPLICATIONS FOR THE
COGNITIVE AND EMOTIONAL
DYSFUNCTIONS OF PSYCHOSIS
It has been argued that schizophrenia is a syndrome not a
disease: a set of symptoms, and other measurable signs, often
seen together (Kotov et al., 2011; MacDonald, 2013). Assemblies
of these failures, based on their relative co-occurrence, has led to
our current diagnostic neo-Kraepelinian scheme. However, two
patients labeled schizophrenic can both fulfill the current criteria
without sharing any symptoms while simultaneously resembling
patients not classified as schizophrenic. From a neo-Kraepelinian
perspective, this is troubling. There is a clear need for a new
framework that diagnoses patients in a new way.
Syndromal diseases are caused by multiple upstream faults
resulting in a spectrum of symptoms, and no single cause defines
the disease. The fault tree maps the likelihood of symptoms to the
likelihood of cognitive and affective failures and in turn linking
those failures to the likelihood of upstream faults in neural
systems and genetic polymorphisms. This perspective allows for
Frontiers in Human Neuroscience | www.frontiersin.org 4 January 2016 | Volume 9 | Article 698
MacDonald et al. Integrating Insults: Fault Tree Analysis
FIGURE 2 | Specific example of a fault tree generated from results of Neymotin et al. (2011). The authors used a computational model to investigate the
conditions under which the power of theta frequency oscillations (3–12 Hz) decrease while the power of gamma frequency oscillations (30–100 Hz) increase, as seen
in animals and human patients after ketamine administration (Ehrlichman et al., 2009; Hong et al., 2010; Lazarewicz et al., 2010). In their computational model, a
decrease in theta power resulted when NMDA receptors (NMDARs) were blocked in either the somas of oriens-lacunosum moleculare (OLM) cells or in the apical
dendrites of pyramidal cells, regardless of the function of NMDARs in other cell types. In the same model, an increase in gamma power occurred only when
NMDARs were blocked in the somas of OLM cells and NMDARs were not blocked in basket cells or the apical dendrites of pyramidal cells. Thus, the only
combinations which generated both an increase in gamma power and a decrease in theta power involved blocking NMDARs in OLM soma with intact NMDARs in
basket cells and pyramidal apical dendrites; the state of NMDARs in the pyramidal basal dendrites did not affect these results and can thus be said to be irrelevant in
this case. Generation of a fault tree from these results allows one to visualize the roles that each factor plays in multiple downstream effects. Additional, unknown,
factors may also impact the phenotype.
the overlap of symptoms seen across syndromes. The fault tree’s
logic gates relate the different components of the genomics and
physiology into a biometric. While the goal is to generate an
overall model that explains the direct mechanistic connections
underlying the indirect correlations, this can be approached
one step at a time. Parts of a fault tree can be assembled
from existing data, perhaps using probabilistic graphical models,
to link different elements at adjacent scales and correlational
relationships between elements at nonadjacent scales. For
example, linking genetic mutations to cell pathophysiology, or
cell excitability to network oscillations. But links also occur
between scales that are not directly coupled, such as correlations
between genes and disease prevalence. The fault tree can
bring these lines of evidence together to make predictions for
interventions that can be tested with computational models and
validated in animal models and clinical studies. In this regard,
studies of the neural systems of the cognitive and emotional
dysfunctions in people with psychosis, including schizophrenia,
will play a critical role.
There are limitations to the fault tree metaphor. Physiology
may not fall into a neat tree-like structure. A tree implies that
there is directionality in the causality: genes are responsible for
cellular physiology and physiology is responsible for behavior.
However, in biological systems there is clearly feedback between
each of these levels, which will require attention. Furthermore,
the schema presented here relies exclusively on dichotomous
inputs and outputs. For the most part variables in neuroscience
are measurable quantities, frequencies or probabilities. This
concern has been considered and has been addressed within the
field of reliability engineering. The expansion of the Boolean
fault tree into one with more realistic kinds of variables is an
additional refinement. Studies of patients can aid in this effort
by providing more data about the distributions of their measured
variables. For example, the relative skew of patient and control
distributions for neural variables is relatively unknown; such data
provide important additional information for validly predicting
the likelihood of rare events. Another challenge is that fault tree
analyses are top-down, and therefore, even with computational
modeling, require a good deal of prior knowledge. One way to
address this challenge in large data sets with insufficient prior
knowledge is the use of probabilistic graphical models, which can
bootstrap these efforts from the bottom-up.
The ultimate goal in developing a new diagnostic schema is to
identify combination therapies that will maximize benefits. Fault
trees can help identify how genetic, pharmacologic or behavioral
therapies can improve, and inform cost/benefit analyses when
considering treatment options. This approach may also inform
public health policy, helping to identify disease mechanisms for
which intervention has not yet been fully exploited. A fault
tree provides a formal way of relating disparate sources of
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information about disease mechanisms and symptoms into one
framework. Most importantly, it provides a path to move beyond
a diagnostic scheme to one that directs therapies and research to
maximize patient benefit.
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